Paris Saclay Seed Fund
Investment Stage: Seed
Portfolio 21
| Date | Name | Website | Total Raised | Location |
| 21.02.2023 | twitter.com | $3.99B | United Sta... | |
| 07.12.2022 | Evaneos | evaneos.fr | $102.2M | Italy |
| 18.04.2022 | union54 (Y... | union54.com | $15.13M | Zambia, Lu... |
| 07.02.2022 | Channable | channable.com | $62.99M | Argentina,... |
| 17.09.2021 | Billogram | billogram.com | $61.17M | Sweden, St... |
| 01.12.2020 | Material E... | material-exchange.com | $35.15M | Sweden, St... |
| 30.06.2020 | Symmetrica... | symmetrical.ai | $32.87M | United Kin... |
| 23.06.2020 | MoneyFello... | moneyfellows.com | $51.6M | Egypt, Cai... |
| 12.12.2019 | Upvest | upvest.co | $323.23M | Germany |
| 04.05.2018 | TradeDepot | tradedepot.co | $136M | Nigeria, L... |
Show more
Mentions in press and media 4
| Date | Title | Description |
| 04.02.2022 | Parisian startup revolutionising skin cancer screening raises €5 million to accelerate European rollout | Skin cancers affect over 5 million people worldwide each year and patient prognosis continues to be highly dependent on the timing of diagnosis. Attempting to speed up the diagnosis process is Paris-based medtech company Damae Medical. It h... |
| 22.01.2017 | France, The New Wave of Venture Capital Funds | France is emerging as one of the most active European countries in terms of venture capital investment activity. A trend confirmed by the latest official data available. During the first half of 2016, €5.5 billion were invested in more than... |
| 20.01.2017 | Paris Saclay University Launches €50M Seed Fund | Paris Saclay University has launched a €50m seed fund. The Paris Saclay Seed Fund, which will be run by Partech Ventures with support from Kurma Partners, aims to nurture the new generation of entrepreneurs from the innovation cluster. Led ... |
| - | Parisian startup revolutionising skin cancer screening raises €5 million to accelerate European rollout | Skin cancers affect over 5 million people worldwide each year and patient prognosis continues to be highly dependent on the timing of diagnosis. Attempting to speed up the diagnosis process is Paris-based medtech company Damae Medical. It h... |